The Risk Factors of Hemorrhage in Stereotactic Needle Biopsy for Brain Lesions in a Large Cohort: 10 years of Experience in a Single Center

Overview

Journal Chin Neurosurg J

Publisher Biomed Central

Specialty Neurology

Date 2022 Dec 10

PMID 36494749

Authors

Hailong Li

Chunling Zheng

Wei Rao

Junzhao Sun

Xin Yu

Jianning Zhang

Affiliations

Soon will be listed here.

Abstract

Background: This study aimed to identify the risk factors for hemorrhage from a large cohort who underwent stereotactic needle biopsy for brain lesions at a single center over a 10-year period.

Methods: We performed a retrospective chart review of consecutive patients who underwent stereotactic biopsy at our institute between January 2010 and December 2019. Demographic characteristics and clinical variables were collected and analyzed to identify risk factors for postbiopsy hemorrhage using the chi-square test and univariable and multivariable logistic regression analyses.

Results: A total of 3196 patients were included in this study; of these, a histological diagnosis was eventually made for 2938 (91.93%) patients. Hemorrhage occurred in 149 (4.66%) patients, and symptomatic hemorrhage occurred in 46 (1.44%) patients. In multivariable logistic regression analyses, the presence of deep-seated lesions (OR 1.272, p = 0.035), concomitant edema and enhancement on MR imaging scans (OR 1.827, p = 0.002), intraoperative hypertension without a past history (OR 1.012, p = 0.024), and the presence of high-grade glioma (OR 0.306, p = 0.003) were identified as independent predictors of hemorrhage after biopsy.

Conclusion: Stereotactic needle biopsy is a safe and effective way to obtain tissue from brain lesions for histological diagnosis. The presence of deep-seated lesions, concomitant edema, and enhancement on MR imaging scans and the presence of high-grade glioma are independent predictors of hemorrhage after stereotactic biopsy.

Citing Articles

Implantation Metastasis Following a Biopsy of Thalamic Germinoma: A Case Report.

Yu L, Malilay O, Navarro J Cureus. 2024; 16(11):e74377.

PMID: 39723268 PMC: 11669378. DOI: 10.7759/cureus.74377.

Comparison of Navigated and Frame-Based Stereotactic Biopsy-A Single-Center Cohort Study.

Laskowski M, Pazdziora P, Blaszczyk B, Gola M, Ciekalski M, Koperczak A Medicina (Kaunas). 2024; 60(6).

PMID: 38929566 PMC: 11205312. DOI: 10.3390/medicina60060949.

Stereotactic biopsy for brain lesions: Doing more with less.

Singh M, Ahamed T, Maurya V, Gupta P, Bhaisora K, Srivastava A J Neurosci Rural Pract. 2024; 15(1):95-102.

PMID: 38476427 PMC: 10927046. DOI: 10.25259/JNRP_258_2023.

The safety and accuracy of intratumoral catheter placement to infuse viral immunotherapies in children with malignant brain tumors: a multi-institutional study.

Barkley A, Butler E, Park C, Friedman A, Landi D, Ashley D J Neurosurg Pediatr. 2024; 33(4):359-366.

PMID: 38215438 PMC: 10810678. DOI: 10.3171/2023.12.PEDS23404.

Comparison meta-analysis of intraoperative MRI-guided needle biopsy versus conventional stereotactic needle biopsies.

Dhawan S, Chen C Neurooncol Adv. 2024; 6(1):vdad129.

PMID: 38187873 PMC: 10771274. DOI: 10.1093/noajnl/vdad129.

References

Cheng G, Yu X, Zhao H, Cao W, Li H, Li Q . Complications of stereotactic biopsy of lesions in the sellar region, pineal gland, and brainstem: A retrospective, single-center study. Medicine (Baltimore). 2020; 99(8):e18572. PMC: 7034708. DOI: 10.1097/MD.0000000000018572. View

Williams J, Young C, Vitanza N, McGrath M, Feroze A, Browd S . Progress in diffuse intrinsic pontine glioma: advocating for stereotactic biopsy in the standard of care. Neurosurg Focus. 2020; 48(1):E4. DOI: 10.3171/2019.9.FOCUS19745. View

Shakal A, Mokbel E . Hemorrhage after stereotactic biopsy from intra-axial brain lesions: incidence and avoidance. J Neurol Surg A Cent Eur Neurosurg. 2013; 75(3):177-82. DOI: 10.1055/s-0032-1325633. View

Quick-Weller J, Lescher S, Bruder M, Dinc N, Behmanesh B, Seifert V . Stereotactic biopsy of brainstem lesions: 21 years experiences of a single center. J Neurooncol. 2016; 129(2):243-50. DOI: 10.1007/s11060-016-2166-1. View

Yuen J, Zhu C, Chan D, Ng R, Nia W, Poon W . A sequential comparison on the risk of haemorrhage with different sizes of biopsy needles for stereotactic brain biopsy. Stereotact Funct Neurosurg. 2014; 92(3):160-9. DOI: 10.1159/000360862. View

Chakhoyan A, Yao J, Leu K, Pope W, Salamon N, Yong W . Validation of vessel size imaging (VSI) in high-grade human gliomas using magnetic resonance imaging, image-guided biopsies, and quantitative immunohistochemistry. Sci Rep. 2019; 9(1):2846. PMC: 6391482. DOI: 10.1038/s41598-018-37564-w. View

Grossman R, Sadetzki S, Spiegelmann R, Ram Z . Haemorrhagic complications and the incidence of asymptomatic bleeding associated with stereotactic brain biopsies. Acta Neurochir (Wien). 2005; 147(6):627-31. DOI: 10.1007/s00701-005-0495-5. View

Woodworth G, McGirt M, Samdani A, Garonzik I, Olivi A, Weingart J . Frameless image-guided stereotactic brain biopsy procedure: diagnostic yield, surgical morbidity, and comparison with the frame-based technique. J Neurosurg. 2006; 104(2):233-7. DOI: 10.3171/jns.2006.104.2.233. View

Taweesomboonyat C, Tunthanathip T, Sae-Heng S, Oearsakul T . Diagnostic Yield and Complication of Frameless Stereotactic Brain Biopsy. J Neurosci Rural Pract. 2019; 10(1):78-84. PMC: 6337997. DOI: 10.4103/jnrp.jnrp_166_18. View

10.

Dhawan S, He Y, Bartek Jr J, Alattar A, Chen C . Comparison of Frame-Based Versus Frameless Intracranial Stereotactic Biopsy: Systematic Review and Meta-Analysis. World Neurosurg. 2019; 127:607-616.e4. DOI: 10.1016/j.wneu.2019.04.016. View

11.

Beynon C, Wei S, Radbruch A, Capper D, Unterberg A, Kiening K . Preoperative assessment of haemostasis in patients undergoing stereotactic brain biopsy. J Clin Neurosci. 2018; 53:112-116. DOI: 10.1016/j.jocn.2018.04.035. View

12.

Field M, Witham T, Flickinger J, Kondziolka D, Lunsford L . Comprehensive assessment of hemorrhage risks and outcomes after stereotactic brain biopsy. J Neurosurg. 2001; 94(4):545-51. DOI: 10.3171/jns.2001.94.4.0545. View

13.

Malone H, Yang J, Hershman D, Wright J, Bruce J, Neugut A . Complications Following Stereotactic Needle Biopsy of Intracranial Tumors. World Neurosurg. 2015; 84(4):1084-9. DOI: 10.1016/j.wneu.2015.05.025. View

14.

Kulkarni A, Guha A, Lozano A, Bernstein M . Incidence of silent hemorrhage and delayed deterioration after stereotactic brain biopsy. J Neurosurg. 1998; 89(1):31-5. DOI: 10.3171/jns.1998.89.1.0031. View

15.

McGirt M, Woodworth G, Coon A, Frazier J, Amundson E, Garonzik I . Independent predictors of morbidity after image-guided stereotactic brain biopsy: a risk assessment of 270 cases. J Neurosurg. 2005; 102(5):897-901. DOI: 10.3171/jns.2005.102.5.0897. View

16.

Deb P, Pal S, Dutta V, Boruah D, Chandran V, Bhatoe H . Correlation of expression pattern of aquaporin-1 in primary central nervous system tumors with tumor type, grade, proliferation, microvessel density, contrast-enhancement and perilesional edema. J Cancer Res Ther. 2013; 8(4):571-7. DOI: 10.4103/0973-1482.106542. View

17.

Hu L, Eschbacher J, Dueck A, Heiserman J, Liu S, Karis J . Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade glioma. AJNR Am J Neuroradiol. 2011; 33(1):69-76. PMC: 7966183. DOI: 10.3174/ajnr.A2743. View

18.

Hamisch C, Kickingereder P, Fischer M, Simon T, Ruge M . Update on the diagnostic value and safety of stereotactic biopsy for pediatric brainstem tumors: a systematic review and meta-analysis of 735 cases. J Neurosurg Pediatr. 2017; 20(3):261-268. DOI: 10.3171/2017.2.PEDS1665. View

19.

Kickingereder P, Willeit P, Simon T, Ruge M . Diagnostic value and safety of stereotactic biopsy for brainstem tumors: a systematic review and meta-analysis of 1480 cases. Neurosurgery. 2013; 72(6):873-81. DOI: 10.1227/NEU.0b013e31828bf445. View

20.

de Quintana-Schmidt C, Leidinger A, Molet Teixido J, Bertran G . Application of a Thrombin-Gelatin Matrix in the Management of Intractable Hemorrhage During Stereotactic Biopsy. World Neurosurg. 2018; 121:180-185. DOI: 10.1016/j.wneu.2018.10.053. View